Abstract

The novel compound of the disclosure is 4-chloro-4-(4-ethoxy-phenyl)-2-(fluoren-9-ylidene-hydrazono)-but-3-enoic acid methyl ester (3F-19), and it alone or in combination with 4-(4-Ethoxy-phenyl)-2-(N'-fluoren-9-ylidene-hydrazino)-2-hydroxy-4-oxo-butyric acid methyl ester (OF-13), appears useful in humans as therapeutic means for the eradication of tumors from the human's colon.

Document Type

Patent

Patent Number

US 6,852,876

Application Serial Number

10/164,879

Issue Date

2-8-2005

Current Assignee

UCFRF

Assignee at Issuance

UCFRF

College

College of Sciences

Department

CD3

Allowance Date

10-20-2004

Filing Date

6-7-2002

Assignee at Filing

UCFRF

Filing Type

Nonprovisional Application Record

Donated

no

Share

COinS